• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从超分子水凝胶库中皮下递送针对 SARS-CoV-2 的抗体。

Subcutaneous delivery of an antibody against SARS-CoV-2 from a supramolecular hydrogel depot.

机构信息

Department of Materials Science and Engineering, Stanford University, Stanford, CA 94305, USA.

Department of Biochemistry, Stanford University School of Medicine, Stanford, CA 94305, USA.

出版信息

Biomater Sci. 2023 Mar 14;11(6):2065-2079. doi: 10.1039/d2bm00819j.

DOI:10.1039/d2bm00819j
PMID:36723072
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10012178/
Abstract

Prolonged maintenance of therapeutically-relevant levels of broadly neutralizing antibodies (bnAbs) is necessary to enable passive immunization against infectious disease. Unfortunately, protection only lasts for as long as these bnAbs remain present at a sufficiently high concentration in the body. Poor pharmacokinetics and burdensome administration are two challenges that need to be addressed in order to make pre- and post-exposure prophylaxis with bnAbs feasible and effective. In this work, we develop a supramolecular hydrogel as an injectable, subcutaneous depot to encapsulate and deliver antibody drug cargo. This polymer-nanoparticle (PNP) hydrogel exhibits shear-thinning and self-healing properties that are required for an injectable drug delivery vehicle. drug release assays and diffusion measurements indicate that the PNP hydrogels prevent burst release and slow the release of encapsulated antibodies. Delivery of bnAbs against SARS-CoV-2 from PNP hydrogels is compared to standard routes of administration in a preclinical mouse model. We develop a multi-compartment model to understand the ability of these subcutaneous depot materials to modulate the pharmacokinetics of released antibodies; the model is extrapolated to explore the requirements needed for novel materials to successfully deliver relevant antibody therapeutics with different pharmacokinetic characteristics.

摘要

为了实现传染病的被动免疫,有必要使治疗相关水平的广泛中和抗体(bnAbs)长时间维持。不幸的是,只要这些 bnAbs 在体内保持足够高的浓度,保护作用就会持续。为了使 bnAbs 的预防和暴露前及暴露后预防变得可行和有效,需要解决药代动力学差和给药负担重这两个挑战。在这项工作中,我们开发了一种超分子水凝胶作为可注射的皮下储库,用于封装和输送抗体药物。这种聚合物-纳米颗粒(PNP)水凝胶具有可注射药物输送载体所需的剪切稀化和自修复特性。药物释放实验和扩散测量表明,PNP 水凝胶可以防止突释并减缓封装抗体的释放。将针对 SARS-CoV-2 的 bnAbs 从 PNP 水凝胶中递送到临床前小鼠模型中,并与标准给药途径进行了比较。我们开发了一个多隔室模型来了解这些皮下储库材料调节释放抗体药代动力学的能力;该模型被外推以探索新型材料成功输送具有不同药代动力学特征的相关抗体治疗药物所需的条件。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b302/10012178/26149c434dab/d2bm00819j-f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b302/10012178/9853d135b6a3/d2bm00819j-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b302/10012178/686a2b9cae4e/d2bm00819j-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b302/10012178/a2080381958b/d2bm00819j-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b302/10012178/d12d5a058751/d2bm00819j-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b302/10012178/af47bf89f5d8/d2bm00819j-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b302/10012178/6825f2bc9ace/d2bm00819j-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b302/10012178/dca75e768763/d2bm00819j-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b302/10012178/26149c434dab/d2bm00819j-f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b302/10012178/9853d135b6a3/d2bm00819j-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b302/10012178/686a2b9cae4e/d2bm00819j-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b302/10012178/a2080381958b/d2bm00819j-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b302/10012178/d12d5a058751/d2bm00819j-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b302/10012178/af47bf89f5d8/d2bm00819j-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b302/10012178/6825f2bc9ace/d2bm00819j-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b302/10012178/dca75e768763/d2bm00819j-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b302/10012178/26149c434dab/d2bm00819j-f8.jpg

相似文献

1
Subcutaneous delivery of an antibody against SARS-CoV-2 from a supramolecular hydrogel depot.从超分子水凝胶库中皮下递送针对 SARS-CoV-2 的抗体。
Biomater Sci. 2023 Mar 14;11(6):2065-2079. doi: 10.1039/d2bm00819j.
2
Subcutaneous delivery of an antibody against SARS-CoV-2 from a supramolecular hydrogel depot.从超分子水凝胶储库皮下递送抗SARS-CoV-2抗体。
bioRxiv. 2022 May 25:2022.05.24.493347. doi: 10.1101/2022.05.24.493347.
3
Broad and Durable Humoral Responses Following Single Hydrogel Immunization of SARS-CoV-2 Subunit Vaccine.单次水凝胶免疫 SARS-CoV-2 亚单位疫苗后产生广泛而持久的体液反应。
Adv Healthc Mater. 2023 Nov;12(28):e2301495. doi: 10.1002/adhm.202301495. Epub 2023 Jun 20.
4
In situ chemically crosslinked injectable hydrogels for the subcutaneous delivery of trastuzumab to treat breast cancer.用于曲妥珠单抗皮下递送的原位化学交联可注射水凝胶治疗乳腺癌。
Acta Biomater. 2019 Mar 1;86:280-290. doi: 10.1016/j.actbio.2019.01.003. Epub 2019 Jan 5.
5
Injectable Nanoparticle-Based Hydrogels Enable the Safe and Effective Deployment of Immunostimulatory CD40 Agonist Antibodies.注射型纳米颗粒水凝胶可安全有效地递呈免疫刺激型 CD40 激动型抗体。
Adv Sci (Weinh). 2022 Oct;9(28):e2103677. doi: 10.1002/advs.202103677. Epub 2022 Aug 17.
6
Hydrogel-based slow release of a receptor-binding domain subunit vaccine elicits neutralizing antibody responses against SARS-CoV-2.基于水凝胶的受体结合域亚单位疫苗缓释可引发针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的中和抗体反应。
bioRxiv. 2021 Aug 29:2021.03.31.437792. doi: 10.1101/2021.03.31.437792.
7
Pharmacokinetic Evaluation of Thermosensitive Sustained Release Formulations Developed for Subcutaneous Delivery of Protein Therapeutics.用于皮下递送蛋白质治疗药物的温敏型缓释制剂的药代动力学评价。
J Pharm Sci. 2023 Mar;112(3):868-876. doi: 10.1016/j.xphs.2022.11.022. Epub 2022 Dec 2.
8
Self-assembled supramolecular thermoreversible β-cyclodextrin/ethylene glycol injectable hydrogels with difunctional Pluronic127 as controlled delivery depot of curcumin. Development, characterization and in vitro evaluation.基于双官能化普朗尼克 127 的自组装超分子热可逆β-环糊精/乙二醇注射水凝胶作为姜黄素的控释储库。制备、表征和体外评价。
J Biomater Sci Polym Ed. 2018 Jan;29(1):1-34. doi: 10.1080/09205063.2017.1396707. Epub 2017 Oct 29.
9
SARS-CoV-2 Neutralization in Convalescent Plasma and Commercial Lots of Plasma-Derived Immunoglobulin.SARS-CoV-2 中和在恢复期血浆和商业的血浆衍生免疫球蛋白产品中。
BioDrugs. 2022 Jan;36(1):41-53. doi: 10.1007/s40259-021-00511-9. Epub 2021 Nov 29.
10
Sustained Delivery of GLP-1 Receptor Agonists from Injectable Biomimetic Hydrogels Improves Treatment of Diabetes.从可注射仿生水凝胶中持续递送胰高血糖素样肽-1受体激动剂可改善糖尿病治疗。
bioRxiv. 2023 Jul 29:2023.01.28.526057. doi: 10.1101/2023.01.28.526057.

引用本文的文献

1
Reinforced Polymer-Nanoparticle Hydrogels for Subcutaneous and Sustained Delivery of Trastuzumab.用于皮下持续递送曲妥珠单抗的增强型聚合物纳米颗粒水凝胶
Adv Healthc Mater. 2025 Jul;14(18):e2404660. doi: 10.1002/adhm.202404660. Epub 2025 Jun 9.
2
Generation of an inflammatory niche in a hydrogel depot through recruitment of key immune cells improves efficacy of mRNA vaccines.通过募集关键免疫细胞在水凝胶贮库中产生炎症微环境可提高mRNA疫苗的疗效。
Sci Adv. 2025 Apr 11;11(15):eadr2631. doi: 10.1126/sciadv.adr2631.
3
Osteopontin attenuates the foreign-body response to silicone implants.

本文引用的文献

1
Injectable Nanoparticle-Based Hydrogels Enable the Safe and Effective Deployment of Immunostimulatory CD40 Agonist Antibodies.注射型纳米颗粒水凝胶可安全有效地递呈免疫刺激型 CD40 激动型抗体。
Adv Sci (Weinh). 2022 Oct;9(28):e2103677. doi: 10.1002/advs.202103677. Epub 2022 Aug 17.
2
Gelation and yielding behavior of polymer-nanoparticle hydrogels.聚合物-纳米颗粒水凝胶的凝胶化和屈服行为
J Polym Sci (2020). 2021 Nov 15;59(22):2854-2866. doi: 10.1002/pol.20210652. Epub 2021 Oct 22.
3
Delivery of CAR-T cells in a transient injectable stimulatory hydrogel niche improves treatment of solid tumors.
骨桥蛋白可减轻对硅酮植入物的异物反应。
Nat Biomed Eng. 2025 Mar 24. doi: 10.1038/s41551-025-01361-4.
4
Sustained Vaccine Exposure Elicits More Rapid, Consistent, and Broad Humoral Immune Responses to Multivalent Influenza Vaccines.持续的疫苗暴露可引发对多价流感疫苗更快速、一致且广泛的体液免疫反应。
Adv Sci (Weinh). 2025 May;12(18):e2404498. doi: 10.1002/advs.202404498. Epub 2025 Mar 17.
5
Pharmacokinetics-Based Design of Subcutaneous Controlled Release Systems for Biologics.基于药代动力学的生物制剂皮下控释系统设计
CPT Pharmacometrics Syst Pharmacol. 2025 Apr;14(4):668-680. doi: 10.1002/psp4.13303. Epub 2025 Jan 24.
6
Recent advances in the exploration and discovery of SARS-CoV-2 inhibitory peptides from edible animal proteins.从可食用动物蛋白中探索和发现新冠病毒抑制肽的最新进展。
Front Nutr. 2024 Feb 7;11:1346510. doi: 10.3389/fnut.2024.1346510. eCollection 2024.
7
Use of a biomimetic hydrogel depot technology for sustained delivery of GLP-1 receptor agonists reduces burden of diabetes management.使用仿生水凝胶储库技术持续递送 GLP-1 受体激动剂可减轻糖尿病管理负担。
Cell Rep Med. 2023 Nov 21;4(11):101292. doi: 10.1016/j.xcrm.2023.101292.
在瞬时可注射的刺激水凝胶龛内递送 CAR-T 细胞可改善实体瘤的治疗效果。
Sci Adv. 2022 Apr 8;8(14):eabn8264. doi: 10.1126/sciadv.abn8264.
4
Safety and Pharmacokinetics of Monoclonal Antibodies VRC07-523LS and PGT121 Administered Subcutaneously for Human Immunodeficiency Virus Prevention.皮下注射单克隆抗体 VRC07-523LS 和 PGT121 用于预防人类免疫缺陷病毒的安全性和药代动力学。
J Infect Dis. 2022 Aug 26;226(3):510-520. doi: 10.1093/infdis/jiac041.
5
Quality assessment of cold chain storage facilities for regulatory and quality management compliance in a developing country context.发展中国家冷链存储设施质量评估:监管和质量管理合规性
Int J Health Plann Manage. 2022 Mar;37(2):930-943. doi: 10.1002/hpm.3385. Epub 2021 Nov 11.
6
Hydrogel-Based Slow Release of a Receptor-Binding Domain Subunit Vaccine Elicits Neutralizing Antibody Responses Against SARS-CoV-2.基于水凝胶的受体结合域亚单位疫苗的缓慢释放可引发针对 SARS-CoV-2 的中和抗体应答。
Adv Mater. 2021 Dec;33(51):e2104362. doi: 10.1002/adma.202104362. Epub 2021 Oct 14.
7
Safety, pharmacokinetics and antiviral activity of PGT121, a broadly neutralizing monoclonal antibody against HIV-1: a randomized, placebo-controlled, phase 1 clinical trial.PGT121,一种针对 HIV-1 的广泛中和单克隆抗体的安全性、药代动力学和抗病毒活性:一项随机、安慰剂对照、1 期临床试验。
Nat Med. 2021 Oct;27(10):1718-1724. doi: 10.1038/s41591-021-01509-0. Epub 2021 Oct 7.
8
Self-Assembled, Dilution-Responsive Hydrogels for Enhanced Thermal Stability of Insulin Biopharmaceuticals.自组装、稀释响应水凝胶提高胰岛素生物药物的热稳定性。
ACS Biomater Sci Eng. 2021 Sep 13;7(9):4221-4229. doi: 10.1021/acsbiomaterials.0c01306. Epub 2020 Nov 17.
9
Consistent tumorigenesis with self-assembled hydrogels enables high-powered murine cancer studies.自组装水凝胶可实现一致的肿瘤生成,从而能够开展高强度的小鼠癌症研究。
Commun Biol. 2021 Aug 19;4(1):985. doi: 10.1038/s42003-021-02500-8.
10
Subcutaneous REGEN-COV Antibody Combination to Prevent Covid-19.皮下注射 REGEN-COV 抗体组合以预防 COVID-19。
N Engl J Med. 2021 Sep 23;385(13):1184-1195. doi: 10.1056/NEJMoa2109682. Epub 2021 Aug 4.